...JHL Biotech Inc. (TPEx-E:6540), Zhubei, Taiwan Jaime De Leon JHL1101 Genentech Inc. JHL Biotech Inc. Medigen Biotechnology Corp. PharmaEngine Inc. Senhwa Biosciences Inc. TaiGen Biopharmaceuticals Holdings Ltd. Roche CD20...

...of the candidates next year. Jaime De Leon dornase alfa Herceptin JHL1101 Pulmozyme Rituxan rituximab Genentech Inc. JHL Biotech Inc. Medigen Biotechnology Corp. PharmaEngine Inc. Senhwa Biosciences Inc. TaiGen Biopharmaceuticals Holdings Ltd. Roche...

...Gilead Sciences Inc. (NASDAQ:GILD); Bristol-Myers Squibb Co. (NYSE:BMY); AbbVie Inc. (NYSE:ABBV); Johnson & Johnson (NYSE:JNJ); TaiGen Biopharmaceuticals Holdings Ltd....

...Gilead Sciences Inc. (NASDAQ:GILD); Bristol-Myers Squibb Co. (NYSE:BMY); AbbVie Inc. (NYSE:ABBV); Johnson & Johnson (NYSE:JNJ); TaiGen Biopharmaceuticals Holdings Ltd....

...Taigen will hold the balance. Based on results of Phase II testing of the combination, TaiGen...
...which TaiGen will hold a 40% stake in the newco and HEC will own 60%. TaiGen...
...HEC Pharm Group , Dongguan, China TaiGen Biopharmaceuticals Holdings Ltd. (TPex:4157), Taipei, Taiwan Business: Infectious Nora Weintraub DAG-181 NS5A inhibitor TG-2349 HEC Pharm Group TaiGen Biopharmaceuticals Holdings Ltd....

...and give the newco Greater China rights to NS5A inhibitor yimitasvir ( DAG-181 ), and TaiGen...
...Taigen will hold the balance. Based on results of Phase II testing of the combination, TaiGen...
...which it will hold a 40% stake in the newco and HEC will own 60%. TaiGen...

...cancer PDUFA date 12/11/16 Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) Plecanatide IBS-C Top-line Ph III data 4Q16 TaiGen Biopharmaceuticals Holdings Ltd....

...NASDAQ:BIIB) EC approves Alprolix eftrenonacog alfa to treat and prevent bleeding in hemophilia B patients TaiGen Biopharmaceuticals Holdings Ltd....

...NASDAQ:SGYP) Plecanatide Irritable bowel syndrome with constipation (IBS-C) Ph III data; submit NDA 3Q16; YE16 TaiGen Biopharmaceuticals Holdings Ltd....